Recombinant VZV ORF9 protein (ab43051)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: ELISA, WB
製品の詳細
-
製品名
Recombinant VZV ORF9 protein
VZV ORF9 タンパク質・ペプチド 製品一覧 -
生理活性
Immunoreactive with sera of VZV-infected individuals. -
精製度
> 95 % SDS-PAGE.
Sepharose derived purification. -
発現系
Escherichia coli -
タンパク質長
Protein fragment -
Animal free
No -
由来
Recombinant -
-
生物種
Varicella zoster virus -
配列の追加情報
The protein contains the VZV ORF9 immunodominant regions.
-
特性
Our Abpromise guarantee covers the use of ab43051 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
ELISA
Western blot
-
製品の状態
Liquid -
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. Store at -20°C.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
関連情報
-
別名
- Gene 9 protein
- HHV3
- Human Herpesvirus 3
see all -
関連性
The varicella-zoster virus (VZV) ORF9 protein is a member of the herpesvirus UL49 gene family but shares limited identity and similarity with the UL49 prototype, herpes simplex virus type 1 VP22. ORF9 mRNA is the most abundantly expressed message during VZV infection; however, little is known concerning the functions of the ORF9 protein. ORF9 protein may form a complex with IE62 and possibly other tegument proteins in the cytoplasm at late times in infection.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (0)
ab43051 は論文での使用が確認できていません。